ProfileGDS5678 / 1454180_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 47% 47% 46% 48% 46% 49% 52% 46% 47% 47% 48% 47% 47% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1603447
GSM967853U87-EV human glioblastoma xenograft - Control 23.1049947
GSM967854U87-EV human glioblastoma xenograft - Control 33.1090147
GSM967855U87-EV human glioblastoma xenograft - Control 43.0350946
GSM967856U87-EV human glioblastoma xenograft - Control 53.0751848
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1661546
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2521649
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.2552752
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0466746
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0807147
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1023247
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1009648
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1155347
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0957147